The Toll-like Receptor Protein Rp105 Regulates Lipopolysaccharide Signaling in B Cells
Open Access
- 26 June 2000
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 192 (1) , 23-30
- https://doi.org/10.1084/jem.192.1.23
Abstract
The susceptibility to infections induced by Gram-negative bacteria is largely determined by innate immune responses to bacteria cell wall lipopolysaccharide (LPS). The stimulation of B cells by LPS enhances their antigen-presenting capacity and is accompanied by B cell proliferation and secretion of large quantities of LPS-neutralizing antibodies. Similar to macrophages and neutrophils, the LPS-induced activation of B cells is dependent on Toll-like receptor (TLR)4. Here, we demonstrate that the responses of B cells to LPS are also regulated by another TLR protein, RP105, which is predominantly expressed on mature B cells in mice and humans. The analysis of mice homozygous for the null mutation in the RP105 gene revealed impaired proliferative and humoral immune responses of RP105-deficient B cells to LPS. Using originally LPS-unresponsive Ba/F3 cells expressing exogenous TLR4 and RP105, we demonstrate the functional cooperation between TLR4 and RP105 in LPS-induced nuclear factor kappaB activation. These data suggest the existence of the TLR4-RP105 signaling module in the LPS-induced B cell activation.Keywords
This publication has 25 references indexed in Scilit:
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- The Molecular Mechanism of B Cell Activation by toll-like Receptor Protein RP-105The Journal of Experimental Medicine, 1998
- Molecular Cloning of a Human RP105 Homologue and Chromosomal Localization of the Mouse and Human RP105 Genes (Ly64andLY64)Genomics, 1996
- Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient miceImmunity, 1995
- Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune diseaseCell, 1995
- Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells.The Journal of Experimental Medicine, 1994
- Lymphocyte populations and immune responses in CD5‐deficient miceEuropean Journal of Immunology, 1994
- The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.Genes & Development, 1993
- pEF-BOS, a powerful mammalian expression vectorNucleic Acids Research, 1990
- IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivoCell, 1985